Table 1 Demographics (N = 583).

From: The effect of polygenic risk score and childhood adversity on transdiagnostic symptom dimensions at first-episode psychosis: evidence for an affective pathway to psychosis

Age, mean ± SD

31.79 ± 10.96

Years of education mean ± SD

12.86 ± 4.02

CTQ total, mean ± SD

41.34 ± 13.28

DSM Diagnosis

 Schizophrenia, N (%)

253 (43.4)

 Other Psychosis, N (%)

150 (25.7)

 Schizoaffective Disorder, N (%)

25 (4.3)

 Bipolar disorder, N (%)

70 (12.0)

 Psychotic depression, N (%)

85 (14.6)

 Sex, Males N (%)

369 (63.3)

 Antidepressants Yes (%)

129 (22.1)

 Antipsychotics Yes (%)

444 (76.2)

 Mood stabilizers Yes (%)

77 (13.2)

 Benzodiazepine Yes (%)

220 (37.7)

  1. Medication: 517 of the 583 patients included in the study had data on antipsychotic medication, mood stabilizers and benzodiazepines. All patients had data on antidepressants. All participants were classified as European based on their Principal Component Analyses.